Biomarker study for biliary tract cancer tissue
Part of Cancer, Digestive system clinical trials.
This study analyzes tumor tissue samples from patients with biliary tract cancer (a rare cancer of the bile ducts or gallbladder) to identify genetic and protein markers that may help doctors better understand and treat the disease. Your stored tissue sample and medical records would be used to find patterns that could improve future treatment options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of biliary tract cancer (gallbladder or bile duct cancer)
- Your cancer diagnosis was made within the last 15 years
- You have archived tumor tissue available from a previous surgery or biopsy
- Your medical records contain basic clinical information and survival data
- You can provide written consent to use your tissue sample and clinical data for research
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tissue samples from people with bile duct, liver, or pancreas problems to develop better ways to detect cancers in these areas. If you are scheduled for a biopsy, scan, or surgery for a suspected growth in your liver, pancreas, or bile duct, you may be able to help.
This study tracks how patients with biliary tract cancer feel and do over time in everyday care, using blood tests and surveys. It aims to understand how symptoms and quality of life relate to the disease and treatment.
This trial tests a combination of radiation therapy (SBRT), two chemotherapy drugs (gemcitabine and cisplatin), and an immunotherapy drug (sintilimab) as a first-line treatment for advanced bile duct cancer that cannot be surgically removed. The goal is to see if this combination can shrink tumors and help patients live longer.
This study looks at lab markers (including genetic tests) to predict how people with bile duct cancer respond to treatment. Your answers and samples may help doctors personalize care for bile duct cancer in the future.
This study looks for new ways to measure cancer-related “biomarkers” (signals in blood or tumor samples) in people with bile duct cancer or gallbladder cancer. The goal is to improve how these cancers are identified and tracked, which could help doctors make better treatment decisions.
This study uses a simple blood test (ctDNA) to learn more about the genetic makeup of advanced biliary tract cancers. It may help researchers understand how these cancers respond to treatment, and it doesn't involve any extra drugs or procedures—just blood draws.
Hear when a new Biliary Tract Cancer (BTC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.